Abstract Background Smoking dependence is a chronic disease and a public health problem. The neurobiology of nicotine addiction can explain smoking behavior. This system has genetic variability that has been associated with vulnerability to dependence. Genetic variability in the neurobiology of smoking can help to understand why individuals exposed to drugs may or may not become addicted. Objective This study aims to address genetic variability in the neurobiology of smoking addiction with a focus on polymorphic genes related to the nicotinic response and the dopaminergic reward pathway. Method This work involved a search of the main scientific research on genetic variability in the neurobiology of smoking and its effects on smoking behavior. One hundred and five studies were selected, most of which highlighted polymorphisms in the genes of nicotinic receptors, dopamine receptors, and nicotine metabolism. Results The majority of studies have focused on genes related to the activation of the dopaminergic reward system by nicotine. Combinations between different polymorphisms were also highlighted, showing that interactions can determine a genetic profile of predisposition to smoking addiction. Additionally, gender and ethnicity were identified as relevant factors. Conclusion Knowledge of the genetic bases involved in the individual response to smoking can enable a better understanding of inter-individual differences in smoking behavior, and contribute to improving the treatment of addiction. problem behavior addicted pathway selected receptors metabolism Additionally factors interindividual inter

Abstract The increasing number of reports of web-based experiences on the success of Cannabis-based therapies in controlling seizures in children suffering from refractory epilepsy have led to efforts by governments and associations to a recent change in legislation. The Brazilian Health Regulatory Agency (ANVISA) allowed the import of Cannabis extracts in 2015 and the registration of the first industrialized drug in 2017. In 2019, ANVISA approved procedures for the granting of a Sanitary Authorization for manufacturing and imports, establishing marketing requirements, prescribing, dispensing, monitoring and surveillance of cannabis products for medicinal purposes. Similar to other consumer products of health concern, is necessary to ensure the quality and health safety of these products worldwide. The aim of the present study to evaluate the presence of As, Cd, Pb, Ni, Cu, Co, Cr and Mn present in Cannabis extracts and resins used in the treatment of pediatric patients with neurological diseases. Samples (48 national and 24 imported) were analyzed by Inductively Coupled Plasma Mass Spectrometry - ICP-MS. The imported extracts presented more homogeneous inorganic element values, while national extracts showed varied levels, thus indicating the highest health risk.

Nanoparticle (NP) applications have recently gained more space in the development of many products, especially in cosmetology. The aim of the present study was to validate a single particle inductively coupled plasma mass spectrometry technique for the detection and quantification of gold nanoparticles (AuNPs) and gold ions (Au (i)) in different cosmetics currently marketed in Brazil. The size limit of detection for pure AuNPs was 22 nm, and a concentration limit of detection of 2.3×106 particles g−1 was achieved. The limit of detection for total gold was 0.02 μg L−1 obtained in standard mode conditions. The recovery achieved was 98% for dissolved Au and 109% for AuNPs; the relative standard deviation was <5%. This validated method was applied to cosmetic products (n= 10) from different national and international industrial producers. Most cosmetics analysed contained quantifiable amounts of dissolved gold (< 0.005-2.1 μg g−1) and only four contained quantifiable amounts AuNPs the variability of the results detected (< LOD – 9.3 × 108particles g−1). The products that contained the greatest amount of these metallic NPs were the artisanal products. The results demonstrate the importance of adequate quality control for cosmetics to ensure consumer safety.

Resumo Introdução O desenvolvimento científico e tecnológico, assim como a adoção de políticas públicas voltadas à redução do custo dos medicamentos, tem ampliado o acesso da população a alternativas terapêuticas, as quais incluem medicamentos genéricos, biossimilares, nanomedicamentos e complexos não biológicos. As categorias já comercializadas exigem procedimentos próprios para a garantia de sua qualidade, eficácia terapêutica e segurança. Nesse contexto, o presente estudo procura realizar uma avaliação do cenário atual no Brasil sobre esse tema, apontando para situações que certamente terão de ser enfrentadas em um futuro próximo. Metodologia Foi realizado um levantamento de dados nas bases eletrônicas MEDLINE, PubMed e SCIELO, buscando artigos originais, tanto em português quanto em inglês, indexados retrospectivamente até 1999. Foram utilizados termos de busca relevantes em língua portuguesa e inglesa. Mais de 50 artigos científicos foram encontrados. Resultados e Discussão A maioria dos artigos avaliados aponta problemas tanto na fabricação quanto no controle de medicamentos genéricos e biossimilares, seja no mercado internacional, seja no nacional. No entanto, novas formas medicamentosas estão sendo criadas e necessitam do desenvolvimento de legislação e de metodologias específicas para a garantia da qualidade desses produtos. Uma avaliação do atual sistema brasileiro de registro e controle da qualidade aponta falhas e, especialmente, falta de uma farmacovigilância mais bem estruturada e ativa no país. Conclusão O atual cenário demonstra que os órgãos responsáveis no país necessitam rever a atual sistemática utilizada na fabricação e controle de medicamentos e aprimorá-la, bem como se preparar para o enfrentamento de outras demandas, algumas ainda mais complexas, que já se encontram em desenvolvimento.

Abstract Introduction Scientific and technological development, as well as the adoption of public policies aiming drugs cost reduction, has broadened the population's access to therapeutic alternatives. These alternatives include generic drugs, biosimilars, nanomedicines and non-biological complexes. Already marketed categories require their own procedures to guarantee their quality, therapeutic efficacy and safety. This article assesses the current Brazilian scenario in this regard, pointing to situations that will surely have to be addressed in a near future. Methodology Data was obtained in the electronic databases MEDLINE, PubMed and SCIELO, searching for original articles, both Portuguese and English, retrospectively indexed back to 1999 using relevant search terms, both in English and in Portuguese. More than 50 scientific articles were found. Results and Discussion Most of the evaluated articles point to problems both in the manufacture and in the control of generic and biosimilar drugs. In fact, scientific publications have proven these problems in the most varied markets including Brazilian. On the other hand, new drug forms are being created and need the development of legislation and specific methodologies to guarantee the quality of these products. An evaluation of the current Brazilian system of registration and quality control points out some flaws and especially the lack of a better structured and active pharmacovigilance in the country. Conclusion The current scenario demonstrates the need of the responsible organs in the country to review the current system and improve it, as well as to prepare for the confrontation with other, even more complex, demands that are already under development.

This work aimed to adapt the analysis of methemoglobin recommended by Evelyn - Malloy (visible spectrophotometry), in order to facilitate its application in the field, or to analysis in clinical laboratory, of existing sites of diflubenzuron application. The parameters changed included: centrifuge rotation speed; time between the collection of biological sample and analysis, and storage temperature of the samples; and the volume of reagents. The comparison of the rotation speed (rpm) of the reference methodology with the rpm of a "clinical centrifuge" did not reveal a statistically significant difference in the levels of methemoglobin. The time between the collection of biological sample and analysis was extended for a period of up to 48 hours for both conservation by refrigeration and ambient temperature, producing no statistically significant difference when compared to the standard duration of 2 hours. Regarding the reagents, the reference methodology already uses the volume necessary to ensure complete reaction, whereas a wider range from the recommended volume to a 5-fold reduction in comparison to the reference methodology could be used. It was concluded that the proposed changes to the methodology for adapting the analysis are applicable to studies of field / workplace exposure and ensure the reliability of results. The adapted methodology was inter-laboratory validated and the parameters changed can be selected according to the requirements of the laboratory at which the methemoglobin is to be measured.

O uso indiscriminado de um número cada vez maior de substâncias químicas vem aumentando e a contaminação ambiental associada tem trazido sérias consequências para o sistema público de saúde devido à elevação de danos para a saúde humana. Uma das substâncias que desperta grande interesse devido à contaminação contemporânea é o benzeno, composto aromático classificado pela International Agency for Research on Cancer como reconhecidamente carcinogênico para humanos. O objetivo do presente estudo foi elaborar e discutir um panorama sobre a contaminação por benzeno, seu metabolismo, consequências para a saúde e sua determinação ambiental e biológica a partir de informações existentes na literatura científica. O levantamento de dados possibilitou o acesso a mais de 200 artigos científicos tanto de âmbito nacional quanto internacional, demonstrando a atualidade do tema e a necessidade de minimização da exposição humana a essa substância. A maioria preocupa-se em explorar o metabolismo e investigar indicadores de exposição, muitos já amplamente estudados e com sérias limitações. Contudo, um crescente número de pesquisadores estão empenhados em elucidar fatores relacionados à suscetibilidade e à interferência da exposição no material genético e proteico. Indicadores de exposição inovadores têm sido propostos com o objetivo de complementar as lacunas de informações anteriormente obtidas, contribuindo para o delineamento da estrutura da biologia de sistemas orgânicos frente à exposição ao benzeno.

The indiscriminate use of an increasing number of chemicals is growing and associated environmental contamination has brought serious consequences for the public health system due to rising damage to human health. One of the substances that have attracted great interest due to contemporary contamination is benzene, aromatic compound classified by International Agency for Research on Cancer as a carcinogen known. The aim of this study was develop and discuss an overview of the contamination by benzene, its metabolism, health endings and their environmental and biological determination based on literature data existing. The survey provided access to more than 200 scientific papers, both nationally and internationally, demonstrating the relevance of the topic and the need to minimize human exposure to this substance. The majority is concerned with exploring the metabolism and investigates indicators of exposure, many already widely studied and with serious limitations. However, a growing number of researchers are committed to elucidate factors related to interference susceptibility and exposure on protein and genetic material. Indicators of innovative exhibition has been proposed with the aim of complementing gaps of information previously obtained, contributing to the design of the structure of the organ biology systems upon exposure to benzene.

Atualmente, a substância utilizada para o combate do vetor da dengue é o diflubenzuron, um larvicida que possui como principal efeito no ser humano a formação demetemoglobina. A determinação do percentual de metemoglobina (MHb) no sangue permite estabelecer a relação com a exposição ao diflubenzuron, sendo utilizada como indicador de efeito. O objetivo do presente trabalho foi avaliar a efetividade do uso da MHb como indicador da exposição ao diflubenzuron por meio da determinação de sua concentração no sangue de guardas de endemias atuantes em dois municípios do Estado do Rio de Janeiro. Para a avaliação da MHb, foi utilizado o método de análise preconizado por Evelyn-Malloy, a espectrofotometria no visível λmáx=630 nm, e as informações complementares foram obtidas por intermédio da aplicação de questionários semiestruturados. Foi observado que a maioria dos trabalhadores não fazia uso de Equipamento de Proteção Individual (EPI) e atuava em condições de trabalho insalubres e sem treinamento adequado. Houve redução de cerca de 0,05% da concentração da MHb após a exposição ao diflubenzuron, com correlação inversa deste indicador de efeito com a variável fumo (R= -0,742; p=0,035). Dado que a MHb pode ser formada após exposição a diversas substâncias químicas e considerando as dificuldades na logística de execução desta análise, estudos sobre novos biomarcadores mais sensíveis e seletivos são necessários.

Currently, the substance used to combat the dengue vector is diflubenzuron, a larvicide which produces methemoglobin (MHb) in humans. During his working process, applicators may be exposed to this substance at different levels, which depend on the care they adopt in handling and application. Knowing the profile of workers is important to characterize the population and assess the risks they face. The determination of the percentage of MHb in the blood allows to establish a relationship with exposure to diflubenzuron, being used as an indicator of effect. The objective of this study was to evaluate the extent to which these factors can affect the exposure of active endemic guards in two municipalities of the State of Rio de Janeiro contributed to a better understanding of the issues arising from this work process. It was observed that most workers did not use Personal Protective Equipment (PPE) and worked in unsafe working conditions and without proper training. Was observed a large difference in knowledge of the risks arising from the work they perform in the two counties, showing weaknesses in the basic training of these professionals. There was a reduction of about 0.05% of the MHb concentration after exposure to diflubenzuron, with an inverse correlation between this indicator variable effect with smoking (R= -0.742; p=0.035). Since MHb can be formed after exposure to various chemicals and considering the logistical difficulties in implementing this analysis, studies on new more sensitive and selective biomarkers are needed.